Cargando…

Rituximab-Related Reversible Hepatocellular Damage

Detalles Bibliográficos
Autores principales:	Toprak, Selami K., Karakuş, Sema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2012
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781613/ https://www.ncbi.nlm.nih.gov/pubmed/24385734 http://dx.doi.org/10.5505/tjh.2012.98853

Ejemplares similares

Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
por: Toprak, Selami Koçak
Publicado: (2013)

sEPCR Levels in Chronic Myeloproliferative Diseases and Their Association with Thromboembolic Events: A Case-Control Study
por: Atalay, Figen, et al.
Publicado: (2014)

Does Reactive Thrombocytosis Observed in Iron Deficiency Anemia Affect Plasma Viscosity?
por: Toprak, Selami K, et al.
Publicado: (2012)

Thrombosis and risk factors: A comment
por: Toprak, Selami Koçak, et al.
Publicado: (2012)

Successful Treatment of Rituximab-Refractory Waldenstrom Macroglobulinemia-Related Kidney Damage With Bruton Tyrosine Kinase Inhibitor
por: Nie, Guangyan, et al.
Publicado: (2021)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Does Thrombocyte Size Give Us an Idea about Thrombocytosis Etiology?
por: Toprak, Selami Kocak, et al.
Publicado: (2012)

Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015)

Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging
por: Törüner, Murat, et al.
Publicado: (2013)

Acute painful lumbosacral paresthesia after intrathecal rituximab
por: Bromberg, J. E. C., et al.
Publicado: (2011)

Rhodococcus erythropolis Encephalitis in Patient Receiving Rituximab
por: Bagdure, Satish R., et al.
Publicado: (2012)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

Minimization of administration route errors with subcutaneous rituximab
por: Liptrott, Sarah, et al.
Publicado: (2016)

Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
por: Genest, Dominique S., et al.
Publicado: (2021)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Efficacy and maintenance of rituximab treatment in non‐infectious scleritis
por: Vergouwen, Daphne P. C., et al.
Publicado: (2021)

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
por: Dwojak, M, et al.
Publicado: (2015)

Nocardiosis in a renal transplant recipient following rituximab preconditioning
por: Flohr, Tanya R, et al.
Publicado: (2009)

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
por: Buchegger, Franz, et al.
Publicado: (2011)

Acute Myocardial Infarction after First Dose of Rituximab Infusion
por: Gogia, Ajay, et al.
Publicado: (2014)

A rare case of rituximab induced interstitial lung disease
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites
por: Hiroshima, Yuki, et al.
Publicado: (2012)

Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
por: Xu, XiaoWei, et al.
Publicado: (2013)

Fatal Case of Enterovirus 71 Infection and Rituximab Therapy, France, 2012
por: Kassab, Somar, et al.
Publicado: (2013)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

DLBCL developed into fatal liver failure during rituximab-containing chemotherapy
por: Shimazu, Yutaka, et al.
Publicado: (2019)

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report
por: Monteiro, Rowan, et al.
Publicado: (2017)

Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
por: Mino, T, et al.
Publicado: (2014)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
por: Chotaliya, Kiran K., et al.
Publicado: (2015)

The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
por: Kobayashi, T, et al.
Publicado: (2016)

Intrathecal Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Güler, Tülay, et al.
Publicado: (2014)

The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression
por: Wei, Xiaolei, et al.
Publicado: (2014)

Recurrent Bordetella holmesii Bacteremia and Nasal Carriage in a Patient Receiving Rituximab
por: Nguyen, Liem Binh Luong, et al.
Publicado: (2013)

Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid
por: Bernauer, W., et al.
Publicado: (2018)

Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients
por: Woo, Marcel S., et al.
Publicado: (2020)

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
por: Ma, Wanlu, et al.
Publicado: (2021)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation
por: Atilla, Erden, et al.
Publicado: (2017)

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
por: Fink, A M, et al.
Publicado: (2013)

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
por: Sriwijitalai, Won, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t8nuv63bulp51k89hr2hg1kvea